Lenza Pro
- Manufacturer
- Sola Pharmaceuticals
- Effective date
- 2021-01-12
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 6
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:56:51
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Menthol 4%
Lidocaine 4%
OTC - PURPOSE SECTION
Topical Analgesic
INDICATIONS & USAGE SECTION
For the temporarily relief of minor aches and muscle pains associated with arthritis,
simple backache, strains, muscle soreness and stiffness.
WARNINGS SECTION
• Only for external use. Use only as directed. Read and follow all directions and
warnings on this label.
• Do not use: on open wounds, cuts, damaged or infected skin as well as in the
eyes, mouth, genitals, or any other mucous membranes.
• Do not cover with bandage.
• Keep out of reach of children. Consult physician for children under 12.
• Consult your physician: if pregnant or pain persists or worsens or if you
experience signs of skin injury such as pain, swelling, or blistering where product
was applied or if symptoms persist for more than 7 days or clear up and occur
again within a few days.
• If swallowed, get medical help or contact a Poison Control Center right away.
INSTRUCTIONS FOR USE SECTION
• Clean and dry the affected area
• Open pouch and remove one patch
• Remove any protective film and apply directly to affected area of pain
• Wash hands with soap and water after applying patch
• Reseal pouch containing unused patches after each use
INACTIVE INGREDIENT SECTION
Methacrylic acid, ethylhexyl acrylate, bentonite, sodium stearate
OTC - DO NOT USE SECTION
on open wounds, cuts, damaged or infected skin as well as in the
eyes, mouth, genitals, or any other mucous membranes.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Consult physician for children under 12.
WARNINGS SECTION
- Only for external use. Use only as directed. Read and follow all directions and
warnings on this label.
• Do not use: on open wounds, cuts, damaged or infected skin as well as in the
eyes, mouth, genitals, or any other mucous membranes.
• Do not cover with bandage.
• Keep out of reach of children. Consult physician for children under 12.
• Consult your physician: if pregnant or pain persists or worsens or if you
experience signs of skin injury such as pain, swelling, or blistering where product
was applied or if symptoms persist for more than 7 days or clear up and occur
again within a few days.
• If swallowed, get medical help or contact a Poison Control Center right away.
OVERDOSAGE SECTION
In Case of Ingestion or Overdose, get medical help or contact a Poison Control
Center (800-222-1222) right away.
DOSAGE & ADMINISTRATION SECTION
Adults and children 12 years and over: Apply patch to affected area 1 to 2 times
daily or as directed.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Manufactured for : SOLA Pharmaceuticals
655 Highlandia Dr. Ste B
Baton Rouge, LA 70810
Store in a dry, cool place
For Comments or Questions, call 866-747-7365
LenzaPro Patch
Topical Pain Patch
for long lasting relief
NDC 70512-011-15
Qty: 15 Articulated Patches
(5 per Resealable Pouch) x 3
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70512-011-15 | EA - Each | 70512-011 | bdc2d70b-cf3e-44e4-ad4b-44b07c5a8cb2 | 1 | 2018-04-19 |
Products#
Every source-derived product name is available through these pages.
- Lenza Pro
- Lidocaine/Menthol Patch
- METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
- 2-ETHYLHEXYL ACRYLATE
- BENTONITE
- CALCIUM STEARATE
- LIDOCAINE
- MENTHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70512-011 | 70512-011-15 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | NX76LV5T8J | IACT |
| 2-ETHYLHEXYL ACRYLATE | HR49R9S6XG | IACT |
| BENTONITE | A3N5ZCN45C | IACT |
| CALCIUM STEARATE | 776XM7047L | IACT |
| LIDOCAINE | 98PI200987 | ACTIB |
| MENTHOL | L7T10EIP3A | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| efcec631-1ed8-4c4c-e053-2995a90a8ed8 | 661ef396-0b38-6e1a-e053-2a91aa0a8352 | 2022-12-14 | Warnings | 661ef396-0b38-6e1a-e053-2a91aa0a8352 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
